MedPath

Clinical study on the Prevention of recurrence of choledocholithiasis after ERCP with Lidan Xiaoshi Mixture

Not Applicable
Recruiting
Conditions
Choledocholithiasis
Registration Number
ITMCTR2000003910
Lead Sponsor
Dongfang Hospital University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who were diagnosed as primary choledocholithiasis by first-line examination (laboratory examination + B-ultrasound) and / or second-line examination (CT or MRCP) and successfully completed ERCP lithotomy;
2. Patients aged from 18 to 70 years old;
3. Patients who did not take choleretic drugs within one month before operation.

Exclusion Criteria

1. Patients without choledocholithiasis or unsuccessful choledocholithotomy;
2. Patients with biliary stricture;
3. Patients with non primary choledocholithiasis such as cholecystolithiasis and hepatolithiasis;
4. Patients with mental illness;
5. Patients with other serious chronic diseases;
6. Pregnant and lactating women.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The recurrence rate;
Secondary Outcome Measures
NameTimeMethod
Bile biochemistry;
© Copyright 2025. All Rights Reserved by MedPath